What is Barclays's price target for PCRX?

Barclays's latest stated price target for Pacira BioSciences Inc. (PCRX) is $27, from its action on Dec 9, 2025.

What is Barclays's rating on PCRX?

Barclays rates PCRX Equal Weight, a neutral rating, as of Dec 9, 2025.

When did Barclays last change its view on PCRX?

On Dec 9, 2025, Barclays starts coverage at Equal Weight, price target $27.

Barclays PCRX price target and rating history

Pacira BioSciences Inc. (PCRX) · Health Care

Barclays rates Pacira BioSciences Inc. (PCRX) Equal Weight with a $27 price target, as of its latest action on Dec 9, 2025. It has published 5 rating actions on PCRX since October 2021, including 0 upgrades and 1 downgrade. Across 4 firms with a PCRX price target in the last 12 months, the median target is $29. Barclays's $27 is 7% below that.

Current rating: Equal Weight
Price target: $27
Median target, all firms: $29
Actions on PCRX: 5

Barclays price target on PCRX

Barclays price target on PCRX, each point a stated target, October 2021 to December 2025.

Every Barclays rating on PCRX

Dec 9, 2025
InitiateBarclays starts coverage at Equal Weight, price target $27
Jul 3, 2024
DowngradeBarclays downgrades to Equal Weight from Overweight, price target $38 to $25
Jan 19, 2022
ReiterateBarclays raises its price target to $96 from $92, keeps Overweight
Nov 5, 2021
ReiterateBarclays raises its price target to $92 from $91, keeps Overweight
Oct 1, 2021
ReiterateBarclays cuts its price target to $91 from $95, keeps Overweight

How other firms rate PCRX

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Oppenheimer	Outperform	$32	Sep 23, 2026
Leerink Partners	Market Perform	$28	Sep 9, 2026
Truist Securities	Buy	$30	Aug 17, 2026
Barclays	Equal Weight	$27	Dec 9, 2025
H.C. Wainwright	Buy		Nov 17, 2025

Questions about Barclays and PCRX

What is Barclays's price target for PCRX?: Barclays's latest stated price target for Pacira BioSciences Inc. (PCRX) is $27, from its action on Dec 9, 2025.
What is Barclays's rating on PCRX?: Barclays rates PCRX Equal Weight, a neutral rating, as of Dec 9, 2025.
When did Barclays last change its view on PCRX?: On Dec 9, 2025, Barclays starts coverage at Equal Weight, price target $27.
How does Barclays's PCRX target compare with other analysts?: Across 4 firms with a PCRX price target in the last 12 months, the median target is $29. Barclays's $27 is 7% below that.

More PCRX rating histories

All Barclays ratings PCRX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.